Labcorp to speak at the Baird 2022 Global Healthcare Conference

BURLINGTON, N.C. --(BUSINESS WIRE)--Sep. 6, 2022-- Labcorp (NYSE: LH), a leading global life sciences company, today announced that members of the executive management team will participate in a fireside chat at the Baird 2022 Global Healthcare Conference on Tuesday, Sept. 13 , at 9:05 a.m. ET .

Focusing on healthcare access for LGBT & TGNB individuals during the pandemic

Labcorp’s Dr. Brian Caveney conducted a fireside interview chat with Dr. Peter Meacher of Callen-Lorde Community Health Center.

Finding silver linings during the pandemic: An interview with Dr. Christopher Dale of Swedish Health System.

  Labcorp’s Dr. Brian Caveney conducted a fireside interview chat with Dr. Christopher Dale of Swedish Health System.

How the pandemic is affecting the evolution of pathology

  Labcorp’s Dr. Brian Caveney conducted a fireside chat with Dr. Carlos Cordon-Cardo of Mount Sinai Health System.

Dr. Caveney interviews three hospital leaders during the early days of the pandemic

In mid-2021, as COVID-19 cases continued to surge, three of Labcorp’s hospital leader partners each sat down for a recorded interview with Dr. Brian Caveney, Chief Medical Officer and President of Labcorp Diagnostics. They shared their experiences from the onset of the pandemic and specific steps they took to overcome new challenges.

Refining your ambulatory laboratory strategy: A guide

Adapting ambulatory lab services in an evolving healthcare landscape is challenging. In our experience, most health systems face three challenges when developing or evaluating their ambulatory lab strategy: Understanding the strategic value, calculating the long-term investment and finding the right partner for success.